Sunhawk announced excellent therapeutic effect of novel anti-microRNA eye drops (called SHJ002) for the treatment of dry eye disease.
SHJ002 was shown to significantly improve both symptoms and signs than placebo. SHJ002 was also demonstrated a good safety profile and high tolerability.
